850310 | DOBAQ
N-(4-carboxybenzyl)-N,N-dimethyl-2,3-bis(oleoyloxy)propan-1-aminium

Info
DOBAQ
N-(4-carboxybenzyl)-N,N-dimethyl-2,3-bis(oleoyloxy)propan-1-aminium
Data
No
No
C49H83NO6
C 75.24%, H 10.70%, N 1.79%, O 12.27%
>99%
1 Year
-20°C
CAS Number
1360461-69-3
CAS Registry Number is a Registered Trademark of the American Chemical Society
CAS Registry Number is a Registered Trademark of the American Chemical Society
782.186
781.622
References
Lou G, Anderluzzi G, Tandrup Schmidt S, Woods S, Gallorini S, Brazzoli M, Giusti F, Ferlenghi I, Johnson R, Roberts CW, O'Hagan DT, Baudner BC, Perrie Y. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection. J Control Release. 2020 Jun 30:S0168-3659(20)30362-X. doi: 10.1016/j.jconrel.2020.06.027. Epub ahead of print. PMID: 32619745.
PubMed ID: 32619745Patel S, Ryals RC, Weller KK, Pennesi ME, Sahay G. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019 Apr 12;303:91-100. doi: 10.1016/j.jconrel.2019.04.015. [Epub ahead of print]
PubMed ID: 30986436
Certificates of Analysis
- Certificate of Analysis (Lot No. 850310C-25MG-A-011 and 5630CJA011)
- Certificate of Analysis (Lot No. 850310P-25MG-A-011 and 5630PJA011)
- Certificate of Analysis (Lot No. 850310P-25MG-B-011 and 5630PJB011)
- Certificate of Analysis (Lot No. 850310P-25MG-C-011 and 5630PJC011)
- Certificate of Analysis (Lot No. 850310P-1G-A-011 and 5630PQA011)
- Certificate of Analysis (Lot No. 850310P-25MG-D-011 and 5630PJD011)
- Certificate of Analysis (Lot No. 850310P-25MG-E-011 and 5630PJE011)
- Certificate of Analysis (Lot No. 850310P-25MG-G-011 and 5630PJG011)
- Certificate of Analysis (Lot No. 850310C-25MG-E-011 and 5630CJE011)
- Certificate of Analysis (Lot No. 850310C-25MG-F-011 and 5630CJF011)
- Certificate of Analysis (Lot No. 850310P-25MG-H-011 and 5630PJH011)